This is a paper that mentions Virosomes and how synthetic peptides, proteins can be used, look at slides 19-23 and other info. Mymetics has many of the patents on Virosomes and is cited in paper. Just speculation here but could be one of the reasons Sanofi is so interested in Mymetics.